The current DUL market cap is 16.87B. The company's latest EPS is USD -3.4955 and P/E is -41.00.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 219.75M | 492.85M | 844.29M | 1.04B | 1.83B |
Operating Income | -939.43M | -828.44M | -708.65M | -785.07M | -282.18M |
Net Income | -886.12M | -858.28M | -852.82M | -1.13B | -440.24M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.4B | 3.41B | 3.64B | 3.55B | 3.83B |
Total Liabilities | 956.44M | 2.39B | 3.06B | 3.7B | 4.05B |
Total Equity | 1.44B | 1.02B | 588.2M | -158.22M | -220.64M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -278.43M | -614.96M | -641.69M | -541.27M | 104.16M |
Investing | -417.68M | -435.52M | -273.3M | 169.35M | -336.35M |
Financing | 823.18M | 994.98M | 1.25B | 425.75M | 172.13M |
Market Cap | 16.87B |
Price to Earnings Ratio | -41.00 |
Price to Sales Ratio | 9.87 |
Price to Cash Ratio | 22.21 |
Price to Book Ratio | -81.8 |
Dividend Yield | - |
Shares Outstanding | 125.95M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 2.15 (1.59%) |
Company Name | Alnylam Pharmace Dl 0001 |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.alnylam.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.